Genomic Surveillance for SARS-CoV-2 - China, September 26, 2022 to January 29, 2023
Description
CONCLUSIONS: This study provides an overview of the prevalence of Omicron variants of SARS-CoV-2 in China. After optimizing COVID-19 prevention and control strategies, no novel Omicron variants of SARS-CoV-2 with altered biological characteristics or
